MedPath
Found 1 clinical trials|View Analysis
Sort by:

Adenomyosis and ART

Phase 4
Recruiting
Conditions
Adenomyosis
Interventions
Drug: Dienogest 2 MG (milligram)
Drug: long GnRH agonist or flexible GnRH antagonist protocol.
Drug: Enantone
First Posted Date
2023-07-10
Last Posted Date
2023-07-10
Lead Sponsor
Azienda Ospedaliero-Universitaria di Modena
Target Recruit Count
500
Registration Number
NCT05937490
Locations
🇮🇹

Azienda Ospedaliero-Universitaria di Modena, Modena, Italy

© Copyright 2025. All Rights Reserved by MedPath